RGS9

Regulator of G-protein signalling 9, also known as RGS9, is a human gene, which codes for a protein involved in regulation of signal transduction inside cells. Members of the RGS family, such as RGS9, are signaling proteins that suppress the activity of G proteins by promoting their deactivation.[supplied by OMIM]

RGS9
Available structures
PDBOrtholog search: PDBe RCSB
Identifiers
AliasesRGS9, PERRS, RGS9L, regulator of G-protein signaling 9, regulator of G protein signaling 9
External IDsOMIM: 604067 MGI: 1338824 HomoloGene: 2845 GeneCards: RGS9
Orthologs
SpeciesHumanMouse
Entrez

8787

19739

Ensembl

ENSG00000108370

ENSMUSG00000020599

UniProt

O75916

O54828

RefSeq (mRNA)

NM_001081955
NM_001165933
NM_003835

NM_001165934
NM_011268

RefSeq (protein)

NP_001075424
NP_001159405
NP_003826

NP_001159406
NP_035398

Location (UCSC)Chr 17: 65.1 – 65.23 MbChr 11: 109.12 – 109.19 Mb
PubMed search
Wikidata
View/Edit HumanView/Edit Mouse

There are two splice isoforms of RGS9 with quite different properties and patterns of expression. RGS9-1 is mainly found in the eye and is involved in regulation of phototransduction in rod and cone cells of the retina, while RGS9-2 is found in the brain, and regulates dopamine and opioid signaling in the basal ganglia.

RGS9-2 is of particular interest as the most important RGS protein involved in terminating signalling by the mu opioid receptor (although RGS4 and RGS17 are also involved), and is thought to be important in the development of tolerance to opioid drugs. RGS9-deficient mice exhibit some motor and cognitive difficulties however, so inhibition of this protein is likely to cause similar side effects.

RGS9 is differentially regulated by Guanine nucleotide-binding protein subunit beta-5 (GNB5) via the DEP domain and DEP helical-extension domain in protein stability and membrane anchor association.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.